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Abstract: An increased incidence of thyroid cancer among 9/11 rescue workers has been reported,
the etiology of which remains unclear but which may, at least partly, be the result of the increased
medical surveillance this group undergoes. This study aimed to investigate thyroid cancer in World
Trade Center (WTC) responders by looking at the demographic data and questionnaire responses of
thyroid cancer cases from the Mount Sinai WTC Health Program (WTCHP). WTCHP thyroid cancer
tumors were of a similar size (p = 0.4), and were diagnosed at a similar age (p = 0.2) compared to a
subset of thyroid cancer cases treated at Mount Sinai without WTC exposure. These results do not
support the surveillance bias hypothesis, under which smaller tumors are expected to be diagnosed
at earlier ages. WTCHP thyroid cancer cases also reported a past history of radiation exposure and a
family history of thyroid conditions at lower rates than expected, with higher than expected rates of
previous cancer diagnoses, family histories of other cancers, and high Body Mass Indexes (BMIs).
Further research is needed to better understand the underlying risk factors that may play a role in the
development of thyroid cancer in this group.
Keywords: thyroid cancer; 9/11 disaster; World Trade Center; surveillance bias
1. Introduction
An increased incidence of thyroid cancer has been reported in the Mount Sinai World Trade Center
(WTC) responders [1], WTC-exposed fire fighters [2], and the New York City (NYC) Department of
Health exposed residents [3] with an excess risk in the range of two to three times the incidence
reported by New York City, New York State, and other national reference populations. This is despite
the fact that established risk factors for thyroid cancer, such as exposure to radiation or iodine-131 [4,5],
have not been reported in connection to Ground Zero [6]. The 9/11 attack did result in residents
and responders being acutely exposed to several carcinogens mixed with dust and particles [1,7–9],
although the direct link with WTC exposure and increased risk of cancer in WTC first responders
remains unclear. Moreover, while the time and length of exposure of these responders have been
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reconstructed from questionnaires, this measure is clearly imprecise as recall bias is an important factor
in a situation of extreme stress [10].
A possible explanation for the excess number of thyroid cancers observed in the responders
cohort is over-diagnosis of thyroid cancer because of increased surveillance [11]. The large number of
respiratory health issues developed by responders after their exposure to WTC dust has prompted
a higher rate of diagnostic imaging of the chest, thus increasing the possibility of a chance thyroid
nodule discovery [12,13]. Preliminary evidence, however, examining the thyroid nodules of WTC first
responders found that all tissue samples tested were positive for biomarkers of malignancy, suggesting
that while surveillance bias may be occurring, over-diagnosis of false-positives cannot sufficiently
explain the excess risk of thyroid cancer observed in this group [14].
Disentangling the roles of various contributors to this excess risk of thyroid cancer would have
major clinical and preventive consequences for the WTC responders. The aims of this study were to
(a) examine non-modifiable demographic factors such as age, sex, race or ethnicity, as well as other
contributing exposures predating thyroid cancer diagnosis; and (b) to better describe these WTC
cancers and the similarities and differences of WTC thyroid cancers to non-WTC thyroid cancers.
2. Methods
2.1. Participant Selection and Enrollment
One of the cohorts in which excess thyroid cancer risk has been observed [1] is the Mount
Sinai World Trade Center Health Program (WTCHP). Responders who participated (as employees or
volunteers) in the rescue, recovery, and cleanup efforts at the WTC sites have been enrolled at Mount
Sinai in the WTCHP, which is funded under the James Zadroga 9/11 Health and Compensation Act
of 2010, on the basis of eligibility criteria including type of duties, site location, and dates and hours
worked [15]. The medical protocol for the monitoring program includes self-administered physical
and mental health questionnaires, as well as a physical examination, laboratory tests, spirometry, and a
chest radiograph [15,16]. Over 27,000 responders have had a least one monitoring visit in the WTCHP
and have consented for their data to be aggregated, of which a total of 20,984 have consented for their
records to be used for medical research [15].
Cancer cases were identified through periodical linkage with the cancer registries of New York,
New Jersey, Pennsylvania, and Connecticut, as these states account for 98% of the responders’
residencies at time of WTCHP enrollment. The full linkage methodology has been described
elsewhere [15]. Only thyroid cancer cases validated by a cancer registry, and only those whose
enrollment into the WTCHP pre-dated their cancer diagnosis, were considered eligible to participate
in this study. Between 2002 and 2013 there were 73 eligible first responders who had developed
thyroid cancer.
Eligible participants were contacted by phone, and those interested in participating were mailed an
initial letter further explaining the research project, along with a consent form and brief questionnaire.
This questionnaire was sectioned, with questions asking about past exposure to radiation, family
medical history, personal medical history, smoking history, and other demographic information.
Participants filled out the questionnaire at home and returned it by mail using a pre-stamped and
pre-addressed return envelope. Participants had the contact information of the research assistant
working on the project if they had any questions. In one case the questionnaire was filled out over the
phone as the participant had trouble reading and writing. A signed copy of their study consents was
mailed back to each participant. Of the 73 participants in the WTCHP cohort of responders who were
eligible to be contacted, four had to be excluded because they did not speak English or because they
had no viable contact information. Of the remaining 69 WTC thyroid cancer cases, 35 (51%) consented
to completing the questionnaire. The study protocol was approved by the Icahn School of Medicine at
Mount Sinai’s Institutional Review Board (IRB-17-01323).
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2.2. Data Processing and Statistical Analysis
Upon return of the questionnaires, the data were input into excel to create a database of
questionnaire responses, and this database was uploaded into SAS for statistical analysis. Some
questionnaire responses were collapsed to make results more interpretable. If a participant reported
having had an X-ray of their head or neck, a computed tomography (CT) scan of their head, neck
or chest, or having had radiation therapy in the head or neck region predating their thyroid cancer
diagnosis they were considered as having had some sort of radiation exposure. A diagnosis of another
cancer was recorded and specified if that cancer diagnosis predated or postdated their diagnosis of
thyroid cancer. BMI was calculated using the self-reported height and weight of the study participants,
and with the cutoffs used for underweight, overweight and obese were <25, 25–30 and >30 kg/m2,
respectively, as suggested by the Center for Disease Control and Prevention [17].
The data obtained from the questionnaires, as well as the initial data reported by the WTCHP (age
at diagnosis, race, gender, histology, marital status, education and smoking status) were compared to
a sample of thyroid cancer from the Mount Sinai Cancer Registry generated by an official from the
Cancer Registry. This sample was limited to those diagnosed with thyroid cancer and treated at Mount
Sinai between 2002 and 2013, in order to cover a comparable time-frame.
Chi-square test, or Fisher’s exact test for small sample size were used to compare WTC and Sinai
Registry data for categorical variables. Wilcoxon Rank Sum Test was used for continuous variables not
normally distributed. All statistical analysis was conducted using SAS version 9.4 (SAS Institute Inc.,
Cary, NC, USA).
3. Results
There were 73 thyroid cancer cases from the WTCHP cohort and these were compared to 949
thyroid cancer cases from the Mount Sinai Cancer Registry. The majority of thyroid cancer cases were
white, both in the WTCHP group (71.9%) and in the Mount Sinai Cancer Registry (70.2%) (p = 0.8).
There was, however, a statistically significant difference in gender (p < 0.0001), with WTCHP cases
more likely to be male (78.1%). There was no significant difference between the two groups in terms
of tumor size (p = 0.4), and the mean tumor size was small in both the WTCHP and the Mount Sinai
group, 1.4 cm and 1.8 cm, respectively. Age at diagnosis was also similar between the two groups
(p = 0.2); the mean age for those diagnosed after WTC exposure was 48.9 years while the Mount Sinai
Registry mean diagnosis age was 51 years old. There was a statistically significant difference in terms
of histology (p = 0.04), with those in the WTCHP cohort more likely to be diagnosed with a subtype
of papillary carcinoma. There was also a statistically significant difference between the WTCHP and
Mount Sinai group in terms of smoking (p = 0.0385), whereby those in the WTCHP group were more
likely to be current smokers, and in terms of marital status (p < 0.0001), with those in the WTCHP
cohort being more likely to be married (Table 1).
Out of the 69 eligible WTC thyroid cancer cases, 35 (51%) consented to complete the questionnaire.
Those who consented and completed the questionnaire did not differ significantly in terms of race,
gender, age at diagnosis or histology than those who did not participate in the study (data not shown).
A total of 23% of cases reported some sort of radiation exposure. While only 9% reported a family
history of thyroid health issues (either a benign goiter or thyroid cancer), 67% reported a family history
of other cancer types. Additionally, 21% reported a previous history of cancer before the diagnosis
of thyroid cancer. The majority of the study cohort had a BMI between 25 and 30 Kg/m2 (44%) or
>30 kg/m2 (44%). Most participants (62%) reported that their thyroid cancer was diagnosed as a
consequence of routine or incidental medical surveillance, and not because they went to a doctor with
symptoms consistent with thyroid cancer (Table 2).
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Table 1. Description of World Trade Center Health Program (WTCHP) and Mount Sinai Registry
thyroid cancer cases.
Demographic and Clinical
Characteristics *
WTCHP (n = 73) Sinai Cancer Registry(n = 949) p Value
n % n %
Race/Ethnicity 0.8177
White 41 71.9 634 70.2
Black 3 5.3 68 7.5
Other 13 22.8 201 22.3
Gender <0.0001
Female 16 21.9 695 73.3
Male 57 78.1 253 26.7
Tumor Size (cm) Mean (1.4) SD (1.2) Mean (1.8) SD (1.9) 0.4053
Age at Diagnosis Mean (48.9) SD (8.0) Mean (51.0) SD (16.2) 0.2252
Histology ˆ 0.0363
Papillary Carcinoma 66 90.4 792 83.5
Papillary Adenocarcinoma NOS (63.6%) (58.7%)
Papillary Carcinoma Follicular Variant (28.8%) (22.0%)
Papillary Microcarcinoma (3.0%) (17.7%)
Papillary Carcinoma Columnar Cell (4.5%) (1.6%)
Other Adenocarcinoma 5 6.9 41 4.3
Oxyphilic Adenocarcinoma (60.0%) (46.3%)
Follicular Adenocarcinoma (40.0%) (53.7%)
Other 2 2.7 116 12.2
Smoking Status 0.0385
Current Smoker 3 5.1 14 1.5
Former or Never Smoker 56 94.9 925 98.5
Marital Status <0.0001
Married or Partnered 42 70.0 519 59.7
Separated or Divorced 12 20.0 56 6.4
Single 3 5.0 241 27.7
Widowed 3 5.0 53 6.1
* Race nWTC = 57, nregistry = 903; gender nWTC = 73, nregistry = 948; tumor size nWTC = 27, nregistry = 753; age
at diagnosis nWTC = 73, nregistry = 949; histology nWTC = 73, nregistry = 94, marital status nWTC = 60, nregistry =
869. ˆ Histology is based on International Classification of Diseases for Oncology (ICD-O-3) coding: Papillary
adenocarcinoma NOS = 8260, oxyphilic adenocarcinoma = 8290, follicular adenocarcinoma NOS = 8330, papillary
carcinoma follicular variant = 8340, papillary microcarcinoma = 8341, papillary carcinoma columnar cell = 8344.
Table 2. WTC thyroid cases questionnaire responses (n = 35).
Exposures and Medical History * n %
Radiation Exposure
Yes 8 22.9
No 27 77.1
Family History of Thyroid Issues
Yes 3 8.8
No 31 91.2
Family History Other Cancer
Yes 22 66.7
No 11 33.3
Personal History of Another Cancer
Before Thyroid Cancer 7 20.6
After Thyroid Cancer or Unknown dx Date 8 23.5
No Other Cancer 19 55.9
BMI (kg/m2)
<25 4 11.8
25–30 15 44.1
>30 15 44.1
Diagnosis Method
Because of Symptoms 21 61.8
Due to Routine Screening or Unrelated Medical Event 13 38.2
* Missing data for family history of other cancer (1), family history of other cancer (2), personal history of other
cancer (1), smoking history (1), BMI (1), diagnosis method (1).
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4. Discussion
Whether or not surveillance bias is occurring in the WTCHP cohort, and the extent to which this
bias may be contributing to the increased incidence of thyroid cancer among first responders, remains
unclear. The similar clinical characteristics observed between the WTCHP responders and those in
the Mount Sinai Registry suggest that the excess risk of thyroid cancer in first responders cannot be
adequately explained by surveillance bias alone. Under the surveillance bias hypothesis, we would
expect increased detection of small thyroid nodules [11,18], yet there was no statistical difference
between the average tumor size of the WTCHP and Mount Sinai Registry groups. Moreover, the
average age at diagnosis was similar between the two groups, while if surveillance bias was introduced
then smaller cancers should have been detected at an earlier age in the WTC cohort. It is important
to consider how surveillance bias may be occurring across the US as a whole; previous research has
found that much of the national increase in thyroid cancer incidence can be attributed to an increase in
small (<1 cm) tumors, unlikely to be found in the absence of routine or incidental surveillance [11].
Moreover, the majority of WTC participants reported that their cancers were diagnosed due to routine
or incidental screening, which may be higher than the expected rate of asymptomatic thyroid cancer
detection [19].
The WTCHP and Mount Sinai thyroid cancer groups statistically differed in terms of gender,
histology, smoking history and marital status; they were not statistically different in terms of race.
Comparison of gender between the two groups, however, is difficult to interpret, since the WTCHP is
composed predominantly of males [20]. WTCHP thyroid cancer cases were more likely to be papillary
histology, which tend to have a favorable prognosis [21]. Moreover, those in the WTCHP cohort
were more likely to be current smokers when compared to the Mount Sinai Registry group, though
the number of reported current smokers was small for both groups. It remains controversial what
affect smoking has on thyroid cancer risk; a decrease in risk of thyroid cancer in men who are current
smokers has actually been observed, although there is no known biological justification for this [22,23].
WTCHP respondents with thyroid cancer were also more likely to be married or have a partner; data
indicate reduced mortality from cancer associated with being married as opposed to being single,
possibly because of increased social support [24].
While WTCHP thyroid cancer cases do not appear to be clinically distinct, their reported risk
factors and carcinogenic exposure history may be uncommon. Only about 23% reported having had
some sort of previous diagnostic radiation exposure before their thyroid cancer diagnosis, while other
studies have found that this number could be as high as 85%, even suggesting this type of radiation
exposure contributes to the carcinogenic process [25].
Increased BMI is also associated with increased risk of thyroid cancer [26] and 44.1% of WTCHP
responders reported a BMI 25–29 km/m2, with an additional 44.1% reporting a BMI >30 km/m2.
Neta et al. reported 15.9% and 12% of the thyroid cancer cases having a BMI of 25–29, and≥30 km/m2,
respectively, which is lower than what was observed in the WTCHP cohort. However, these percentages
seem to be in keeping with what has been reported for the overall WTCHP general responder cohort,
suggesting that the thyroid cancer cases represent a random subset of the total group in terms of
BMI [25].
Moreover, few WTCHP responders (8.8%) reported in their questionnaire that they had a family
history of thyroid cancer or benign thyroid issues. Having a first-degree relative with thyroid cancer
is known to increase thyroid cancer risk [27]. Other studies have found that as high as 15.6% of
thyroid cancer cases report a family history of thyroid cancer [25,28]. A family history of another
malignant disease has also been shown to be associated with thyroid cancer [29], and having a family
history of cancer was reported by 66.7% of WTCHP respondents. This is higher than reported by
past research, which found that 49% of thyroid cancer cases reported a family history of cancer in
first-degree relative [29]. It is possible that some WTC respondents may have reported past cancers of
relatives more distant than first-degree relatives, thus inflating the statistic.
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Having a previous cancer diagnosis has also been shown to be associated with thyroid cancer [30],
and 20.6% of WTCHP respondents reported having had another cancer before being diagnosed with
thyroid cancer. This is higher than what was reported in the SEER database [31], where only 10.9%
of thyroid cancer cases had another cancer predating thyroid cancer diagnosis. It is possible that
this is related to the fact that WTC responders are at an increased risk for several types of cancer,
including prostate cancer [1]; an alternative explanation could be an increased familial risk among
WTCHP responders.
The WTCHP responders were also likely (23.5%) to develop a second primary cancer after thyroid
cancer, which is in keeping with the observed increase in risk of secondary cancers associated with
a primary thyroid cancer [32]. This number is higher, however, than what would be expected based
on SEER registry data, whereby just 8% of thyroid cancer cases developed a second type of tumor.
Again, it remains unclear if this increased risk of multiple primary cancers is because of WTC dust and
debris exposure having a carcinogenic effect on 9/11 first responders or because of other genetic or
environmental factors.
This study had some limitations, which includes a small sample size that may have been affected
by recall bias, since participants were asked about past exposure and family history. Although selection
bias could have been possible, an attempt was made to verify that those who participated were not
statistically different from those who chose not to.
Among the strengths, this study represents an important contribution to the literature by helping
to fill the gap in understanding why 9/11 first responders experience an increased risk of thyroid
cancer. The descriptive epidemiology presented here will hopefully inform future, more in-depth
studies that may explain this phenomenon. Future research on germline and somatic tumor alterations
of these cancers may help to shed light on the possibility of a WTC-related carcinogenic mechanism.
5. Conclusions
Cancer surveillance of WTC first responders should continue, and specifically thyroid health
should be part of regular screening procedures. Ultrasound techniques instead of radiation-based
diagnostic procedures might be a more appropriate first step approach.
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